Skip to Content

Live Oak Health Sciences LOGSX

Medalist Rating as of | See Oak Associates Investment Hub
  • NAV / 1-Day Return 21.44  /  +0.33 %
  • Total Assets 53.1 Mil
  • Adj. Expense Ratio
    1.020%
  • Expense Ratio 1.020%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Health
  • Investment Style Large Blend
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield 0.65%
  • Turnover 47%

USD | NAV as of Jun 20, 2024 | 1-Day Return as of Jun 20, 2024, 10:18 PM GMT+0

Morningstar’s Analysis LOGSX

Will LOGSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Live Oak Health Sciences's Average Process Pillar and People Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LOGSX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 43.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Regeneron Pharmaceuticals Inc

5.71 3.1 Mil
Healthcare

McKesson Corp

5.24 2.8 Mil
Healthcare

Cencora Inc

5.06 2.7 Mil
Healthcare

Amgen Inc

4.70 2.5 Mil
Healthcare

The Cigna Group

4.19 2.3 Mil
Healthcare

Molina Healthcare Inc

3.97 2.1 Mil
Healthcare

Elevance Health Inc

3.79 2.0 Mil
Healthcare

Cardinal Health Inc

3.78 2.0 Mil
Healthcare

Intuitive Surgical Inc

3.71 2.0 Mil
Healthcare

Exelixis Inc

3.71 2.0 Mil
Healthcare